EMCDDA: 30 years
Description
The source data for this graphic is available in the source table on this page.
| Date | Description | Label |
|---|---|---|
| 1993 | Institutional | Adoption and entry into force of Council Regulation establishing the EMCDDA |
| 1994 | Cooperation | First meetings of the EMCDDA Management Board, Scientific Committee and Reitox network |
| 1995 | Institutional | EMCDDA opens in Lisbon under its first Director Georges Estievenart |
| 1996 | Drug situation | First Annual report on the state of the drugs problem in Europe |
| 1997 | NPS | Early Warning System on new synthetic drugs established |
| 1998 | NPS | MBDB becomes the first new synthetic drug risk assessed |
| 1999 | NPS | 4-MTA is the first new synthetic drug brought under control following risk assessment |
| 2000 | Responses | Evaluation Instruments Bank launched online offering tools for evaluating drug-related interventions |
| 2001 | Cooperation | Norway joins the EMCDDA |
| 2002 | Drug situation | First report on the drug situation in the candidate Central and Eastern European Countries |
| 2003 | Cooperation | Reitox Operating Framework adopted |
| 2004 | Cooperatoin | 10 new Member States join the EMCDDA following EU enlargement |
| 2005 | Institutional | Wolfgang Götz takes up post as Director |
| 2006 | Events | President of the European Commission José Manuel Durão Barroso visits EMCDDA |
| 2007 | Cooperation | Bulgaria and Romania join the agency following EU enlargement |
| 2008 | Responses | Best practice portal launched |
| 2009 | Events | Conference ‘Identifying Europe’s information needs for effective drug policy’ |
| 2010 | Events | First European conference on drug supply indicators |
| 2011 | Markets | Trendspotter meeting on recent shocks in the European heroin market |
| 2012 | Training | First European Drugs Summer School (EMCDDA–ISCTE) |
| 2013 | Markets | First EU Drug Markets Report (EMCDDA–Europol) |
| 2014 | Cooperation | Turkey joins the EMCDDA |
| 2015 | Events | First Lisbon Addictions conference |
| 2016 | Institutional | Alexis Goosdeel takes up post as Director |
| 2017 | Responses | First Health and social responses to drug problems: a European guide |
| 2018 | NPS | New legislation brings faster response to new drugs |
| 2019 | Responses | Agency launches standardised prevention training curriculum |
| 2020 | Training | EMCDDA webinars series launched |
| 2021 | Institutional | Development of a new EMCDDA business model |
| 2022 | NPS | 25 years of the EU Early Warning System on NPS |
| 2023 | Institutions | Preparations for a new mandate paving the way for the European Union Drugs Agency |